Where Lyra Therapeutics Stands With Analysts
Where Lyra Therapeutics Stands With Analysts
Lyra Therapeutics 在分析师中的立场
Analysts' ratings for Lyra Therapeutics (NASDAQ:LYRA) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
5位分析师提供的分析师对Lyra Therapeutics（纳斯达克股票代码：LYRA）在上个季度的评级从看涨到看跌不等。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的评级，展示了过去30天情绪的演变，并将其与前几个月进行了比较。
Analysts have recently evaluated Lyra Therapeutics and provided 12-month price targets. The average target is $7.5, accompanied by a high estimate of $12.00 and a low estimate of $0.50. A decline of 31.82% from the prior average price target is evident in the current average.
分析师最近对Lyra Therapeutics进行了评估，并提供了12个月的目标股价。平均目标为7.5美元，最高估计值为12.00美元，低估值为0.50美元。目前的平均价格比先前的平均目标股价下降了31.82％。
Decoding Analyst Ratings: A Detailed Look
解码分析师评级：详细介绍
A comprehensive examination of how financial experts...
对金融专家如何...
登录免费看全文
登录/注册